{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:25:39Z","timestamp":1780485939373,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["JP19K18970"],"award-info":[{"award-number":["JP19K18970"]}]},{"name":"JSPS KAKENHI","award":["23K15986"],"award-info":[{"award-number":["23K15986"]}]},{"name":"JSPS KAKENHI","award":["JP22K17026"],"award-info":[{"award-number":["JP22K17026"]}]},{"name":"JSPS KAKENHI"},{"DOI":"10.13039\/501100023535","name":"Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University","doi-asserted-by":"publisher","award":["Tokyo Dental College Well-being Project"],"award-info":[{"award-number":["Tokyo Dental College Well-being Project"]}],"id":[{"id":"10.13039\/501100023535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-024-01326-w","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T12:09:21Z","timestamp":1736424561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Administration of Bisphosphonate Preparations to Mice with Mild-type Hypophosphatasia Reduces the Quality of Spontaneous Locomotor Activity"],"prefix":"10.1007","volume":"116","author":[{"given":"Aki","family":"Nakamura-Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seikou","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"issue":"4","key":"1326_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte MP (2016) Hypophosphatasia\u2014aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12(4):233\u2013246","journal-title":"Nat Rev Endocrinol"},{"key":"1326_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","volume":"102","author":"MP Whyte","year":"2017","unstructured":"Whyte MP (2017) Hypophosphatasia: an overview for 2017. Bone 102:15\u201325","journal-title":"Bone"},{"issue":"9","key":"1326_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00198-019-04921-y","volume":"30","author":"AA Khan","year":"2019","unstructured":"Khan AA et al (2019) Hypophosphatasia: Canadian update on diagnosis and management. Osteoporos Int 30(9):1713\u20131722","journal-title":"Osteoporos Int"},{"issue":"4","key":"1326_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00774-020-01193-z","volume":"39","author":"A \u0130nci","year":"2021","unstructured":"\u0130nci A et al (2021) Hypophosphatasia: is it an underdiagnosed disease even by expert physicians? J Bone Miner Metab 39(4):598\u2013605","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"1326_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00198-022-06597-3","volume":"34","author":"E Ng","year":"2023","unstructured":"Ng E et al (2023) A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients. Osteoporos Int 34(2):327\u2013337","journal-title":"Osteoporos Int"},{"issue":"11","key":"1326_CR6","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/jbmr.4130","volume":"35","author":"L Seefried","year":"2020","unstructured":"Seefried L et al (2020) Burden of illness in adults with hypophosphatasia: data from the global hypophosphatasia patient registry. J Bone Miner Res 35(11):2171\u20132178","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1326_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s13023-022-02572-7","volume":"17","author":"J Feurstein","year":"2022","unstructured":"Feurstein J et al (2022) Identifying adult hypophosphatasia in the rheumatology unit. Orphanet J Rare Dis 17(1):435","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"1326_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","volume":"75","author":"E Mornet","year":"2011","unstructured":"Mornet E et al (2011) A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet 75(3):439\u2013445","journal-title":"Ann Hum Genet"},{"issue":"23","key":"1326_CR9","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.3390\/jcm10235676","volume":"10","author":"S Tournis","year":"2021","unstructured":"Tournis S et al (2021) Hypophosphatasia. J Clin Med 10(23):5676","journal-title":"J Clin Med"},{"issue":"1","key":"1326_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1515\/cclm-2023-0427","volume":"62","author":"T Gonz\u00e1lez-Cejudo","year":"2024","unstructured":"Gonz\u00e1lez-Cejudo T et al (2024) Mild hypophosphatasia may be twice as prevalent as previously estimated: an effective clinical algorithm to detect undiagnosed cases. Clin Chem Lab Med 62(1):128\u2013137","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"1326_CR11","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/jbmr.4801","volume":"38","author":"W Zhou","year":"2023","unstructured":"Zhou W et al (2023) Prevalence of monogenic bone disorders in a Dutch cohort of atypical femur fracture patients. J Bone Miner Res 38(6):896\u2013906","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1326_CR12","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1359\/jbmr.081253","volume":"24","author":"MP Whyte","year":"2009","unstructured":"Whyte MP (2009) Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res 24(6):1132\u20131134","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1326_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jbmr.1565","volume":"27","author":"RA Sutton","year":"2012","unstructured":"Sutton RA et al (2012) \u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res 27(5):987\u2013994","journal-title":"J Bone Miner Res"},{"issue":"9","key":"1326_CR14","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/jbmr.2495","volume":"30","author":"T Cundy","year":"2015","unstructured":"Cundy T et al (2015) Reversible deterioration in hypophosphatasia caused by renal failure with bisphosphonate treatment. J Bone Miner Res 30(9):1726\u20131737","journal-title":"J Bone Miner Res"},{"key":"1326_CR15","doi-asserted-by":"publisher","first-page":"115407","DOI":"10.1016\/j.bone.2020.115407","volume":"137","author":"MR McClung","year":"2020","unstructured":"McClung MR, Ebetino FH (2020) History of risedronate. Bone 137:115407","journal-title":"Bone"},{"key":"1326_CR16","doi-asserted-by":"publisher","first-page":"890696","DOI":"10.3389\/fchem.2022.890696","volume":"10","author":"B Kaboudin","year":"2022","unstructured":"Kaboudin B et al (2022) Hydroxy- and amino-phosphonates and -bisphosphonates: synthetic methods and their biological applications. Front Chem 10:890696","journal-title":"Front Chem"},{"key":"1326_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41413-018-0029-4","volume":"6","author":"W Liu","year":"2018","unstructured":"Liu W et al (2018) Alpl prevents bone ageing sensitivity by specifically regulating senescence and differentiation in mesenchymal stem cells. Bone Res 6:27","journal-title":"Bone Res"},{"issue":"6","key":"1326_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00223-020-00676-5","volume":"106","author":"A Nakamura-Takahashi","year":"2020","unstructured":"Nakamura-Takahashi A et al (2020) High-level expression of alkaline phosphatase by adeno-associated virus vector ameliorates pathological bone structure in a hypophosphatasia mouse model. Calcif Tissue Int 106(6):665\u2013677","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"1326_CR19","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.joms.2014.07.004","volume":"72","author":"S Cheong","year":"2014","unstructured":"Cheong S et al (2014) Bisphosphonate uptake in areas of tooth extraction or periapical disease. J Oral Maxillofac Surg 72(12):2461\u20132468","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"1326_CR20","doi-asserted-by":"publisher","first-page":"7672","DOI":"10.1038\/s41598-021-87375-9","volume":"11","author":"FRN de Sousa","year":"2021","unstructured":"de Sousa FRN et al (2021) The effect of high concentration of zoledronic acid on tooth induced movement and its repercussion on root, periodontal ligament and alveolar bone tissues in rats. Sci Rep 11(1):7672","journal-title":"Sci Rep"},{"issue":"10","key":"1326_CR21","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.3390\/ijms21103620","volume":"21","author":"K Mizutani","year":"2020","unstructured":"Mizutani K et al (2020) Inflammatory skin-derived cytokines accelerate osteoporosis in mice with persistent skin inflammation. Int J Mol Sci 21(10):3620","journal-title":"Int J Mol Sci"},{"key":"1326_CR22","first-page":"100515","volume":"21","author":"K Yokoi","year":"2019","unstructured":"Yokoi K et al (2019) Clinical and genetic aspects of mild hypophosphatasia in Japanese patients. Mol Genet Metab Rep 21:100515","journal-title":"Mol Genet Metab Rep"},{"issue":"4","key":"1326_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10735-020-09891-8","volume":"51","author":"J Zhang","year":"2020","unstructured":"Zhang J et al (2020) Interaction between C\/EBP\u03b2 and RUNX2 promotes apoptosis of chondrocytes during human lumbar facet joint degeneration. J Mol Histol 51(4):401\u2013410","journal-title":"J Mol Histol"},{"key":"1326_CR24","doi-asserted-by":"publisher","first-page":"680585","DOI":"10.3389\/fphar.2021.680585","volume":"12","author":"M Zhang","year":"2021","unstructured":"Zhang M et al (2021) Xanthohumol attenuated inflammation and ECM degradation by mediating HO-1\/C\/EBP\u03b2 pathway in osteoarthritis chondrocytes. Front Pharmacol 12:680585","journal-title":"Front Pharmacol"},{"issue":"3","key":"1326_CR25","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/ar1922","volume":"8","author":"S Koelling","year":"2006","unstructured":"Koelling S et al (2006) Cartilage oligomeric matrix protein is involved in human limb development and in the pathogenesis of osteoarthritis. Arthritis Res Ther 8(3):R56","journal-title":"Arthritis Res Ther"},{"issue":"16","key":"1326_CR26","doi-asserted-by":"publisher","first-page":"9253","DOI":"10.3390\/ijms23169253","volume":"23","author":"J Cui","year":"2022","unstructured":"Cui J, Zhang J (2022) Cartilage oligomeric matrix protein, diseases, and therapeutic opportunities. Int J Mol Sci 23(16):9253","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1326_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s004290050098","volume":"196","author":"I Mizoguchi","year":"1997","unstructured":"Mizoguchi I et al (1997) Localization of types I, II and X collagen and osteocalcin in intramembranous, endochondral and chondroid bone of rats. Anat Embryol (Berl) 196(4):291\u2013297","journal-title":"Anat Embryol (Berl)"},{"issue":"12","key":"1326_CR28","first-page":"2066","volume":"143","author":"S Paul","year":"2016","unstructured":"Paul S et al (2016) Ihha induces hybrid cartilage-bone cells during zebrafish jawbone regeneration. Development 143(12):2066\u20132076","journal-title":"Development"},{"issue":"1","key":"1326_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41413-020-00115-z","volume":"8","author":"J Kushioka","year":"2020","unstructured":"Kushioka J et al (2020) A novel negative regulatory mechanism of Smurf2 in BMP\/Smad signaling in bone. Bone Res 8(1):41","journal-title":"Bone Res"},{"key":"1326_CR30","doi-asserted-by":"publisher","first-page":"14570","DOI":"10.1038\/ncomms14570","volume":"8","author":"Z Xu","year":"2017","unstructured":"Xu Z et al (2017) SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts. Nat Commun 8:14570","journal-title":"Nat Commun"},{"issue":"1","key":"1326_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1297\/cpe.29.9","volume":"29","author":"T Michigami","year":"2020","unstructured":"Michigami T et al (2020) Clinical practice guidelines for hypophosphatasia. Clin Pediatr Endocrinol 29(1):9\u201324","journal-title":"Clin Pediatr Endocrinol"},{"issue":"12","key":"1326_CR32","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.4158\/EP-2018-0194","volume":"24","author":"MN Vinan-Vega","year":"2018","unstructured":"Vinan-Vega MN, Abate EG (2018) Hypophosphatasia: clinical assessment and management in the adult patient-a narrative review. Endocr Pract 24(12):1086\u20131092","journal-title":"Endocr Pract"},{"issue":"9","key":"1326_CR33","first-page":"1285","volume":"25","author":"M Yamauchi","year":"2015","unstructured":"Yamauchi M, Sugimoto T (2015) On \u201c2015 guidelines for prevention and treatment of osteoporosis\u201d. Medical treatment for osteoporosis. Clin Calcium 25(9):1285\u20131292","journal-title":"Clin Calcium"},{"key":"1326_CR34","doi-asserted-by":"publisher","first-page":"115262","DOI":"10.1016\/j.bone.2020.115262","volume":"133","author":"L Bessueille","year":"2020","unstructured":"Bessueille L et al (2020) Tissue-nonspecific alkaline phosphatase is an anti-inflammatory nucleotidase. Bone 133:115262","journal-title":"Bone"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01326-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-024-01326-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-024-01326-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:21:31Z","timestamp":1766755291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-024-01326-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1326"],"URL":"https:\/\/doi.org\/10.1007\/s00223-024-01326-w","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have no conflicts of interest with respect to this study other than those stated in the Funding section.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was approved by the Tokyo Dental College Animal Experimentation Committee and the Recombinant DNA Experiment Safety Committee (approval numbers: 300706, DNA2101). The study protocol also complied with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"30"}}